Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Palmitoylethanolamide (PEA) is a naturally occurring lipid molecule that functions as an anti-inflammatory and analgesic agent. It primarily acts by activating PPAR-alpha, leading to the suppression of inflammatory gene expression and stabilizing mast cells. It is considered a safe and well-tolerated non-steroidal option, particularly for dermatological applications and potentially for systemic inflammation-related disorders.
Activation of PPAR-alpha leading to reduced transcription of pro-inflammatory genes; mast cell stabilization; modulation of TRPV1 channels; interaction with GPR55/GPR119 receptors.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Palmitoylethanolamide (PEA).